SANGAMO THERAP.INC.DL-,01SANGAMO THERAP.INC.DL-,01SANGAMO THERAP.INC.DL-,01

SANGAMO THERAP.INC.DL-,01

No trades
See on Supercharts

Price target

4.570.000.00%
The 5 analysts offering 1 year price forecasts for GBY have a max estimate of — and a min estimate of —.

Analyst rating

Based on 7 analysts giving stock ratings to GBY in the past 3 months.

EPS

Reported
Estimate
Reported
Estimate
Surprise

Revenue

Reported
Estimate
Reported
Estimate
Surprise
Be warned

Frequently Asked Questions


GBY EPS for the last quarter is −0.11 EUR despite the estimation of −0.09 EUR. In the next quarter EPS is expected to reach −0.08 EUR. Track more of SANGAMO THERAP.INC.DL-,01 financials and stay on top of what is up with the company.
In the next quarter SANGAMO THERAP.INC.DL-,01 revenue is expected to reach ‪17.84 M‬ EUR. Check out SANGAMO THERAP.INC.DL-,01 revenue and earnings and make informed decisions.
According to analysts, GBY price target is 4.57 EUR with a max estimate of 9.14 EUR and a min estimate of 1.83 EUR. Check if this forecast comes true in a year, meanwhile watch SANGAMO THERAP.INC.DL-,01 stock price chart and keep track of the current situation with GBY news and stock market news.
We've gathered opinions of 7 analysts rating GBY stock in the past 3 months. Most of them backed up the strong buy trend, and after taking into account other opinions, the overall rating was calculated as buy. Note that it's not a trading advice — your own analysis is still required.